Oncotarget Immunotherapy Response in Pancreatic Cancer: What a New Study Reveals Identification and analyses of exceptional responders could eventually offer hints as to why PC is... read more September 11, 2025
Oncotarget Immunotherapy Safety for Hepatocellular Carcinoma in Latin America: Insights from a Real-World Study Latin America has been underrepresented in trials evaluating immunotherapy for hepatocellular carcinoma (HCC)."Liver cancer,... read more July 2, 2025
Oncotarget Exploring a Combined Approach: Radiation and Immunotherapy in Bladder Cancer Different treatment strategies are required for the non-muscle-invasive, muscle-invasive, and metastatic stages of bladder cancer."... read more June 16, 2025
Oncotarget A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1 The anti-correlation of PD-1 and KLRG1 expression in human tumor infiltrating CD8 T cells suggests... read more January 28, 2025
Oncotarget CDR3s and Renalase-1 Correlate with Increased Melanoma Survival Our group has demonstrated that chemical complementarity between tumor resident, T-cell receptor, complementarity-determining region 3 (... read more September 26, 2024
Oncotarget Impact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast Cancer In this new study, researchers assessed the feasibility of treating HR+/HER2-negative breast cancer patients... read more June 20, 2024
Oncotarget Immunotherapy Response in Primary vs Metastatic Pancreatic Cancer In this editorial, researchers delve into the immunotherapeutic challenges posed by the tumor microenvironment and... read more November 16, 2023
Oncotarget Immunotherapy Response Predicted by Machine Learning & Gut Microbiomes Researchers investigated common gut microbiome features of response among immunotherapy patients with different advanced-stage cancers.... read more September 1, 2022
Oncotarget Epigenetics and Immunotherapy Combined Fights Rare Lymphoma In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more August 24, 2022
Oncotarget Behind the Study: Evaluations in TRAMP Prostate Cancer Model Dr. Yves Chabu from the Department of Biological Sciences at the University of Missouri describes... read more September 20, 2021